Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica an... (22 3.4 Revenue 23 3.5 Major Mark...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta

Date:11/28/2011

3.4 Revenue 23

3.5 Major Marketed Pain Management Drugs 24

3.5.1 Lyrica (pregabalin) 25

3.5.2 Cymbalta (duloxetine) 26

3.5.3 Celebrex (celecoxib) 26

3.5.4 Voltaren Gel (diclofenac sodium) 27

3.5.5 Imitrex(sumatriptan succinate) 27

3.5.6 Savella (milnacipran hydrochloride) 28

3.5.7 Lidoderm (lidocaine patch) 28

3.5.8 Qutenza (capsaicin) 28

3.5.9 Zomig (zolmitriptan) 29

3.5.10 Maxalt (rizatriptan benzoate) 29

3.6 Annual Cost of Therapy 30

3.7 Treatment Usage Patterns 31

3.7.1 Diseased Population 33

3.7.2 Treatment Seeking Population 34

3.7.3 Diagnosed Population 35

3.7.4 Prescription Population 36

3.8 Drivers and Restraints of the Pain Management Therapeutics Market 37

3.8.1 Drivers 37

3.8.2 Restraints 38

4 Pain Management Therapeutics Market - Therapeutic Landscape 39

4.1 Pain Management Therapeutics Market for Fibromyalgia 39

4.1.1 Introduction 39

4.1.2 Revenue 40

4.1.3 Branded vs. Generic Share 41

4.1.4 Annual Cost of Therapy 42

4.1.5 Treatment Flow Algorithm 43

4.1.6 Treatment Usage Patterns 44

4.1.7 Geographical Segmentation 50

4.1.8 Drivers and Restraints for the Fibromyalgia Market 53

4.1.9 Restraints for the Fibromyalgia Pain Relief Market 54

4.2 Pain Management Therapeutics for Neuropathic Pain 54

4.2.1 Introduction 54

4.2.2 Revenue 55

4.2.3 Branded Vs Generic Share 56

4.2.4 Annual Cost of Therapy 57

4.2.5 Treatment Flow Algorithm 58

4.2.6 Treatment Usage Patterns 59

4.2.7 Geographical Segmentation 64

4.2.8 Drivers and Restraints for the Neuropathic Pain Market 66

4.2.9 Drivers 67

4.2.10 Restraints 67

4.3 Pain Management Therapeutics Market for Migraine 68

4.3.1 Introduction 68

4.3.2 Revenue 68

4.3.3 Branded Vs Generic Share 69

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine technology :

1. Philips Introduces Veradius Neo Mobile C-arm With Flat Detector to Enhance Management of Challenging Patients and Procedures
2. Denali Concrete Management Inc. Announces its Acquisition of CF101 for Ophthalmic Indications and the Completion of Above $6 Million Private Placement at $1.144 Per Share
3. KJAYA Medical Honored with 2011 Frost & Sullivan Award for Technology Innovation in Web-based Medical Imaging Data Management
4. MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
5. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
6. Prime Therapeutics Launches Retail Medication Therapy Management Program
7. MedBox Medication Dispensing: Reducing Preventable ER Trips Through Better Medication Management
8. Orthofeet Expands Sales and Operations Management
9. NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution
10. Sleep HealthCenters Launches PAPCenter™ PAP Therapy Compliance Management Program
11. Rapid Fire Marketing: Medical Cannabis Management Signs Agreement with Second Non-Profit

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 PRNewswire – ... production of a vaccine candidate for the newly ... party laboratory using the iBioLaunch™ platform. This validation ... from initial antigen sequence information to purification of ... ) The iBioLaunch platform eliminates ...

(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...

(Date:5/21/2013)... BEIJING, May 21, 2013 Concord Medical Services ... CCM ), a leading specialty hospital management solution ... and diagnostic imaging centers in China and the parent ... results for the first quarter ended March 31, 2013 ... , Total net revenue, which consists of net revenues ...

[0] iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile [0] Concord Medical Reports First Quarter 2013 Financial Results

... (Nasdaq: IDEV ) today announced that it ... and Drug Administration (FDA) for,VALSTAR(R). VALSTAR, a sterile ... product approved by the FDA for therapy of,bacillus ... bladder. VALSTAR was removed from the market ...

... 17 Dendreon Corporation,(Nasdaq: DNDN ) today ... study,of NEUVENGE, an investigational active cellular immunotherapy, in ... Oncology. The article highlights,the safety profile, immune response ... breast cancer who have failed standard,therapy. "In ...

Cached Medicine Technology:Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2 Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3 Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 2 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 3 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 4

Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

(Date:5/22/2013)... from a large observational study reported at ... superior to heparin in the absence of ... patients with non-ST segment elevation acute coronary ... European and US NSTE-ACS guidelines currently recommend ... heparin plus GP IIb/IIIa receptor inhibitors in ...

(Date:5/22/2013)... MA (PRWEB) May 22, 2013 In ... hit the country’s fields and courts with donated ... Sports, a Massachusetts-based nonprofit dedicated to partnering with manufacturers ... is celebrating the donation of $8.8 million in sports ... more than a half-million kids outfitted for physical activity. ...

(Date:5/22/2013)... Following the success of last year’s ... Fit Body Boot Camp Kincardine has announced it will ... starting on June 3rd at its Kincardine fitness ... Kincardine, Ontario. , Fit Body Boot Camp’s 1,000 lb. ... community residents to lose a total of 1,000 pounds ...

(Date:5/22/2013)... Jersey City, NJ (PRWEB) May 22, 2013 ... governance, compliance, and management solutions for social enterprise ... Partners, LLC, a consulting firm based in Chicago, ... to integrate their products and provide best-in-class solutions ... productivity and improve collaboration. , AvePoint’s DocAve ...

(Date:5/22/2013)... adherence to appropriate medication therapy has been shown to ... 125,000 deaths in the U.S. every year are attributed ... estimated that between 33% and 69% of all medication-related ... a reality that costs the American health-care system approximately ... degree of medication non-adherence — and the consequences therefrom ...

Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2 Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2 Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3 Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2

[0] Registry questions superiority of bivalirudin over heparin [0] Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity [0] Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity [0] AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration [0] Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance

... 25 Former NFL player and Dallas Cowboy,Jason Kaiser ... graduation ceremony. Kaiser earned the title of,valedictorian with a ... people in,this school and in my class especially," he ... Before enrolling in Parker College, Kaiser played professional football,for ...

... protein levels could key future treatments for Alzheimer,s , , ... finds that where protein-destroying machines reside in the brain,s ... a finding that may play a role in future ... Wake Forest University School of Medicine researchers studying mice ...

... his left eyebrow was possibly skin cancer , , FRIDAY, ... during his lifetime, historians have gone to great lengths ... of Franklin Delano Roosevelt, the 32nd president of the ... and heart disease is now well-documented. But a new ...

... QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today reported financial results ... otherwise, all amounts are in U.S. dollars,and in accordance ... 2008, we were pleased to report the U.S. Food,and ... blood,monitoring from the Aczone(TM) label," said Bob Butchofsky, President ...

... Inc., (a wholly owned,subsidiary of Mentice AB), a ... the field of medicine, has recently appointed,Jeff Sirek ... Clinical,Applications Manager for the Americas., Jeff Sirek ... years with GE Healthcare in its Cardiovascular Ultrasound,Division ...

... Solutions, Inc. announced,today the addition of Dr. Marc ... serve as Vice President of Research and Development ... of spine,system/orthopedic development experience, most recently having directed,development ... Marc to Facet Solutions bolsters an already great,team, ...

Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate When It Comes to Memory, It's All About Location FDR Might Have Had Melanoma QLT announces first quarter results for 2008 Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.Facet Solutions, Inc. Expands Executive Management Team

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Netromycin, Random Level Netilmicin, Random Level Neopterin Level Neonatal 5 Drug Panel, Meconium